Nalluri Amends Avalon Holdings Stake Filing
Ticker: AWX · Form: SC 13D/A · Filed: Aug 16, 2024 · CIK: 1061069
| Field | Detail |
|---|---|
| Company | Avalon Holdings Corp (AWX) |
| Form Type | SC 13D/A |
| Filed Date | Aug 16, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.01, $10,171.25, $4,098.19, $6,073.06, $2.39 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, sec-filing, amendment
Related Tickers: AWX
TL;DR
Nalluri updated his Avalon Holdings filing on 8/16. Keep an eye on this one.
AI Summary
Anil Choudary Nalluri, M.D. has filed an amendment (39) to Schedule 13D for Avalon Holdings Corporation, dated August 16th, 2024. The filing concerns the Class A Common Stock of Avalon Holdings Corporation. Nalluri's address is listed as 3954 Montereale Drive, Canfield, Ohio 44406.
Why It Matters
This filing indicates a change or update in the ownership or control of Avalon Holdings Corporation by a significant shareholder, potentially impacting the company's stock price and strategic direction.
Risk Assessment
Risk Level: medium — Schedule 13D filings often signal significant changes in a company's ownership structure, which can lead to increased volatility.
Key Players & Entities
- Anil Choudary Nalluri, M.D. (person) — Filing person and beneficial owner
- Avalon Holdings Corporation (company) — Subject company
- Class A Common Stock (security) — Class of securities being reported
- August 16th 2024 (date) — Date of event requiring filing
FAQ
What specific changes are detailed in Amendment 39 to the Schedule 13D filing?
The filing itself is an amendment, but the specific details of the changes are not provided in the header information. Further review of the full document is required.
Who is Anil Choudary Nalluri, M.D. in relation to Avalon Holdings Corporation?
Anil Choudary Nalluri, M.D. is the individual filing the Schedule 13D amendment, indicating he is a significant beneficial owner of Avalon Holdings Corporation's Class A Common Stock.
What is the CUSIP number for Avalon Holdings Corporation's Class A Common Stock?
The CUSIP number for Avalon Holdings Corporation's Class A Common Stock is 0534P109.
When was the event that required this Schedule 13D/A filing to be made?
The date of the event which requires filing of this statement is August 16th, 2024.
What is the business address and phone number provided for the person authorized to receive notices?
The address is 3954 Montereale Drive, Canfield, Ohio 44406, and the telephone number is 330-783-1147.
Filing Stats: 4,508 words · 18 min read · ~15 pages · Grade level 4.4 · Accepted 2024-08-16 07:01:00
Key Financial Figures
- $0.01 — Name of Issuer) Class A Common Stock, $0.01 par value (Title of Class of Securiti
- $10,171.25 — drawal Available Cash [ Bod1palem -8501 $10,171.25 $4,098.19 $6,073.06 Transaction Time pe
- $4,098.19 — lable Cash [ Bod1palem -8501 $10,171.25 $4,098.19 $6,073.06 Transaction Time period From
- $6,073.06 — [ Bod1palem -8501 $10,171.25 $4,098.19 $6,073.06 Transaction Time period From To l All T
- $2.39 — AVALON HOLDINGS CORP UNSOLICITED TRADE@ $2.39 (Order 110009) unassrgned -3,585.( 08/1
- $2.34 — AVALON HOLDINGS CORP UNSOLICITED TRADE@ $2.34 (Order 110000) Unassrgned -7,488( Bough
- $2.16 — AVALON HOLDINGS CORP UNSOLICITED TRADE@ $2.16 (Order 19949) Un8SS1gned -3.240.( 07/08
- $2.20 — AVALON HOLDINGS CORP UNSOLICITED TRADE@ $2.20 (Order 19945) Unass1gned -580.1 Bought
- $2.15 — AVALON HOLDINGS CORP UNSOLICITED TRADE@ $2.15 (Order 19944) Unassigned -2n. Bought 60
- $2.1599 — AVALON HOLDINGS CORP UNSOLICITED TRADE@ $2.1599 (Order 19943) Unassigned -1,295. 06/28/
- $2.1598 — AVALON HOLDINGS CORP UNSOLICITED TRADE@ $2.1598 (Order 19943) Unass1gned -861 Bought 18
- $2.14 — VALON HOLDINGS CORP UNSOLICITED TRADE @ $2.14 (Order 19938) Unass1gned -385~ 06/20/2A
- $2 — VALON HOLDINGS CORP UNSOLICITED TRADE @ $2 1474 (Order 9932) Unass1gned -472. 06/2
- $2.158 — AVALON HOLDINGS CORP UNSOLICITED TRADE@ $2.158 (Order 119930) Unassigned -4,316.1 06/2
- $2.152 — AVALON HOLDINGS CORP UNSOLICITED TRADE@ $2.152 (Order 19928) Unassigned -1.936 06/20/2
Filing Documents
- d874861dsc13da.htm (SC 13D/A) — 77KB
- g874861dsp006.jpg (GRAPHIC) — 354KB
- g874861dsp007.jpg (GRAPHIC) — 461KB
- g874861dsp008.jpg (GRAPHIC) — 342KB
- g874861dsp009.jpg (GRAPHIC) — 323KB
- g874861dsp010.jpg (GRAPHIC) — 300KB
- g874861dsp011.jpg (GRAPHIC) — 269KB
- g874861dsp012.jpg (GRAPHIC) — 306KB
- g874861dsp013.jpg (GRAPHIC) — 284KB
- g874861dsp014.jpg (GRAPHIC) — 331KB
- g874861dsp015.jpg (GRAPHIC) — 384KB
- g874861dsp016.jpg (GRAPHIC) — 327KB
- g874861dsp017.jpg (GRAPHIC) — 278KB
- 0001193125-24-201652.txt ( ) — 5536KB
From the Filing
SC 13D/A 1 d874861dsc13da.htm SC 13D/A SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment 39)* AVALON HOLDINGS CORPORATION (Name of Issuer) Class A Common Stock, $0.01 par value (Title of Class of Securities) 0534P109 (CUSIP Number) Anil Choudary Nalluri, M.D. 3954 Montereale Drive Canfield Ohio 44406 330-783-1147 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 16th 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. CUSIP No. 05343P109 13D 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Anil Choudary Nalluri 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Source of Funds (See Instructions) PF 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization United States Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 1,092,356 8. Shared Voting Power 0 9. Sole Dispositive Power 1,092,356 10. Shared Dispositive Power 0 11. Aggregate Amount Beneficially Owned by Each Reporting Person 1,092,356 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) 13. Percent of Class Represented by Amount in Row (11) 14. Type of Reporting Person (See Instructions) IN 2 Item1. Security and Issuer This Statement on Schedule 13D (Schedule 13D) relates to the Class A Common Stock, $0.01 par value (the Common Stock) of Avalon Holdings Corporation, an Ohio corporation (the Issuer), whose principal executive offices are located at One American Way, Warren, Ohio 44484. Item2. Identity and Background This statement is filed by Anil Choudary Nalluri (Dr. Nalluri or the Reporting Person) on behalf of himself and his wife, Parvati Nalluri and various accounts controlled by them. Dr Nalluris principal business address is 3954 Montereale Drive Canfield Ohio 44406. Dr. Nalluris principal occupation is practicing in the field of psychiatry. During the past five years, Dr. Nalluri has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) and has not been a party to civil proceedings of a judical or administrative body of competent jurisdiction, as a result of which Dr. Nalluri was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Dr. Nalluri is a United States citizen. 3 Item3. Source and Amount of Funds or Other Consideration Dr. Nalluris purchases of shares of Common Stock have all been made with his personal funds. Item4. Purpose of Transaction The purpose of this filing is to state that Dr. Nalluri is the beneficial owner of greater than 20% of the Common Stock of the issuer. Doctor Nalluri does not currently have any specific plans or proposals that relate to or would result in any of the actions or events specified in clauses (a) through (j) of Item 4 of Schedule 13D. Mr. Nalluri reserves the right to change plans and take any and all actions that Dr. Nalluri may deem appropriate to maximize the value of his investments, including, among other things, purchasing or otherwise acquiring additional securities of the Issuer, selling or otherwise disposing of any securities of the Issuer beneficially owned by him, in each case in the open market or in privately negotiated transactions, or fomulating other plans or pro